Overview

Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali

Status:
Unknown status
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The main objective is to study the pharmacokinetics, pharmacodynamics and tolerability of the decoction of the aerial parts of Argemone mexicana (AM), administered in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
University of Bamako
Collaborator:
University of Geneva, Switzerland
Treatments:
Antimalarials